Margaret Dalesandro insider trades: Seelos Therapeutics (SEEL) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Margaret reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 26, 2022 | SEEL | ↑ Buy | 35,000 | $0.60 | $21K | Direct | May 27, 2022 (1d) |
| Aug 23, 2021 | ONCS | ↑ Buy | 20,000 | $1.89 | $38K | Direct | Aug 25, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Margaret Dalesandro's insider trades
Margaret Dalesandro is a director at Seelos Therapeutics (SEEL). Since Aug 23, 2021, Margaret has reported 2 open-market purchases worth $59K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SEEL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.